...
首页> 外文期刊>Clinical journal of gastroenterology >Successful natural interferon-P plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-alpha treatment due to arrhythmia and interstitial pneumonia
【24h】

Successful natural interferon-P plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-alpha treatment due to arrhythmia and interstitial pneumonia

机译:慢性丙型肝炎患者因心律不齐和间质性肺炎而中断α-干扰素治疗后,成功的天然干扰素-P +利巴韦林治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A 71-year-old female patient with hepatitis C virus genotype 1 had previously discontinued interferon (IFN)-a plus ribavirin therapy, pegylated IFN-alpha (peglFN-a) monotherapy, and natural IFN-alpha monotherapy because of arrhythmia, interstitial pneumonia, and severe neuro-vegetative symptoms. She subsequently completed 72 weeks of natural IFN-beta plus ribavirin therapy without remarkable adverse effects and achieved a sustained viral response, suggesting differences in the pharmacological properties and biological effects of IFN-alpha and IFN-beta Thus, natural IFN-beta plus ribavirin therapy may be a treatment option for patients with poor tolerance to IFN-alpha or peglFN-a treatments.
机译:一名71岁的1型丙型肝炎病毒女性患者因心律不齐,间质性肺炎而停止使用干扰素(IFN)-a加利巴韦林治疗,聚乙二醇化IFN-α(peglFN-a)单一疗法和天然IFN-α单一疗法。 ,以及严重的神经营养症状。随后,她完成了72周的天然IFN-β加利巴韦林治疗,而没有明显的不良反应,并实现了持续的病毒反应,表明IFN-α和IFN-β的药理特性和生物学作用存在差异。因此,天然IFN-β加利巴韦林治疗对于IFN-α或peglFN-a治疗的耐受性差的患者可能是一种治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号